HIGHLIGHTS
SUMMARY
The management of COVID-19 mortality in cancer patients is gradually improving, but many questions regarding the impact of COVID-19 on cancer remain. The Eastern Cooperative Oncology Group (ECOG) established that morbidity and mortality are greater in subjects with an ascertained COVID-19 diagnosis and cancer than in cancer free patients. Complicating factors include the various treatment regimens for both cancer and COVID-19, the temporal relationship between cancer stages and COVID-19 exposure, and patient-specific confounders. Despite the lethality of malignant tumors and increased risk following COVID-19 some spontaneous Meo . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.